2018
DOI: 10.1016/j.bbabio.2018.03.018
|View full text |Cite
|
Sign up to set email alerts
|

Bergamot natural products eradicate cancer stem cells (CSCs) by targeting mevalonate, Rho-GDI-signalling and mitochondrial metabolism

Abstract: Here, we show that a 2:1 mixture of Brutieridin and Melitidin, termed "BMF", has a statin-like properties, which blocks the action of the rate-limiting enzyme for mevalonate biosynthesis, namely HMGR (3-hydroxy-3-methylglutaryl-CoA-reductase). Moreover, our results indicate that BMF functionally inhibits several key characteristics of CSCs. More specifically, BMF effectively i) reduced ALDH activity, ii) blocked mammosphere formation and iii) inhibited the activation of CSC-associated signalling pathways (STAT… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
38
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
5
3
1

Relationship

2
7

Authors

Journals

citations
Cited by 58 publications
(39 citation statements)
references
References 57 publications
1
38
0
Order By: Relevance
“…As mentioned above, treatment with various statins targeting CSC self-renewal resulted in elimination of CSCs in breast [34] and brain [86] cancers. Moreover, a mixture of brutieridin and melitidin, which has statin-like properties, eradicates CSCs by targeting mevalonate, Rho-GDI-signaling, and mitochondrial metabolism [123]. In addition, bergamot metabolically inhibits OXPHOS and FAO [123].…”
Section: Cholesterol Synthesis Through the Mevalonate Pathwaymentioning
confidence: 99%
See 1 more Smart Citation
“…As mentioned above, treatment with various statins targeting CSC self-renewal resulted in elimination of CSCs in breast [34] and brain [86] cancers. Moreover, a mixture of brutieridin and melitidin, which has statin-like properties, eradicates CSCs by targeting mevalonate, Rho-GDI-signaling, and mitochondrial metabolism [123]. In addition, bergamot metabolically inhibits OXPHOS and FAO [123].…”
Section: Cholesterol Synthesis Through the Mevalonate Pathwaymentioning
confidence: 99%
“…Moreover, a mixture of brutieridin and melitidin, which has statin-like properties, eradicates CSCs by targeting mevalonate, Rho-GDI-signaling, and mitochondrial metabolism [123]. In addition, bergamot metabolically inhibits OXPHOS and FAO [123].…”
Section: Cholesterol Synthesis Through the Mevalonate Pathwaymentioning
confidence: 99%
“…CIC is involved in many important biochemical pathways, including gluconeogenesis, insulin secretion, inflammation [ 43 , 44 , 45 , 46 ], protein acetylation [ 45 , 47 , 48 ] and innate immune cell function [ 45 ]. Additionally, its activity is decreased during chronic cholestasis [ 49 ], and its inhibition might be useful in nonalcoholic fatty liver disease [ 50 ], as well as in cancer resistance [ 51 , 52 , 53 ] and in apoptosis induction in cancer cells [ 54 ]. The expression of the human CIC (hCIC) is very high in the liver, but this carrier is also expressed in the pancreas and kidney [ 3 ].…”
Section: Drosophila Melanogaster Vs Human Mitomentioning
confidence: 99%
“…Almost always and in both the juice and the cloudy of the three cvs of bergamot, the neohesperidin content was highest in Fantastico (Tables 4-5). Brutieridin and melitidin are two molecules identified and described in the bergamot juice by Di Donna et al [30][31][32][33] and Fiorillo et al [34]. The name brutieridin comes from the ancient name of one of the Calabrian cities (Brutium, today Cosenza) where brutieridin and melitidin were studied, whereas melitidin derives from the name of one of the most important towns (Melito Porto Salvo) where the bergamot tree is cultivated.…”
Section: Flavonoidsmentioning
confidence: 99%